Trials / Completed
CompletedNCT04751292
HIGH Altitude CArdiovascular REsearch Latin America Population Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 937 (actual)
- Sponsor
- Istituto Auxologico Italiano · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
High blood pressure (BP) is one of the principal cardiovascular risk factors. While BP levels and hypertension prevalence are well characterized in many populations, information on BP and on cardiovascular risk profile in high altitude inhabitants is limited and frequently contradictory, especially in the large highland populations of South America. The information on the effects of permanent high altitude exposure on cardiovascular variables including BP may be relevant in the light of the known BP-increasing effect of acute exposure to high altitude hypoxia. This information may have practical implications for millions of people living at elevated altitudes in Asia, South America and Africa. The inconclusive epidemiological evidence on BP and cardiovascular risk in high altitude dwellers may be the result of several factors, among them: 1) confounding by genetic and socio-economic factors; 2) imperfect methods of BP evaluation, in particular lack of data on ambulatory and home BP (both methods considered superior to conventional clinic BP in the assessment of exposure to high BP). On this background, the general aim of the study is to compare blood pressure levels and cardiovascular risk profile among population-based samples of subjects residing in Peruvian communities living at different altitudes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exposure to high altitude | permanence at high (\>2500 m) altitude; permanence is defined as being born and living at high altitude with the total time spent at lower altitudes not exceeding 2 years in the past 10 years |
Timeline
- Start date
- 2021-01-26
- Primary completion
- 2023-12-30
- Completion
- 2023-12-30
- First posted
- 2021-02-12
- Last updated
- 2024-03-01
Locations
1 site across 1 country: Peru
Source: ClinicalTrials.gov record NCT04751292. Inclusion in this directory is not an endorsement.